Herpes zoster, inactivated vaccine (2027)
key details
| Status | complete |
|---|---|
| Procedure | direct |
| OCID | ocds-h6vhtk-066916 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| GlaxoSmithKline UK Limited | £0 | · | pending |
description
The provision of a vaccine to protect against herpes zoster, also known as shingles, to be used in the national immunisation programme.
This notice provides an indication to the market of UKHSA’s intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the herpes zoster, inactivated (shingles) vaccine, in accordance with JCVI advice.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 13 Mar 2026 | Transparency notice (UK5) | Procurement Act 2023 | 022642-2026 |
more from Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
- Vitrocell Exposure System · £99,964 · 28 Jul 2026
- Card Payment Solution (2026 - 2029) · £105,000 · 23 Jul 2026
- Microbiological Safety Cabinet (Porton Down) · £12,488 · 23 Jul 2026
- NW Manchester Telepath LIMS annual support · £121,321 · 23 Jul 2026
- Porton Industrial Automated Control System Works · £1,950,000 · 22 Jul 2026
- Women in Leadership Training for AIA Directorate · 21 Jul 2026
- Provision for Membership to The Global Health Network (Global Health Protection · 20 Jul 2026
- Provision of Haematology Analysers for CDEP · 16 Jul 2026
all contracts from this buyer →
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.